Allergy and Immunology · Hot Springs, AR
NPI
1467497461
Since 2006
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
151 Harmony Park Circle
Hot Springs, AR, 71913
Phone (501) 623-1311
Groups this clinician bills Medicare through
Medicare paid, 2024
$220K
32,522 services
Medicare patients, 2024
621
Average age 74
Drug cost, 2024
$640K
3,385 prescriptions
Company payments, 2025
$985
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Brian D Jackson was code 95004 (test - miscellaneous), 14,072 times for 212 patients. In total Brian D Jackson billed 32,522 services in 19 codes, and Medicare paid $220K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-05-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 14,072 | 212 | $1.93 | $27K |
| 95165 Treatment - Miscellaneous | Office | 11,450 | 257 | $8.78 | $100K |
| 95117 Treatment - Miscellaneous | Office | 5,001 | 199 | $6.98 | $35K |
| 95115 Treatment - Miscellaneous | Office | 1,021 | 46 | $5.73 | $5,848 |
| 99213 Office E&M - Established | Office | 546 | 472 | $54.65 | $30K |
| 99204 Office E&M - New | Office | 124 | 124 | $103.45 | $13K |
| 94010 Pulmonary Function Testing | Office | 87 | 85 | $16.48 | $1,433 |
| 99214 Office E&M - Established | Office | 72 | 70 | $76.87 | $5,534 |
| 94060 Pulmonary Function Testing | Office | 28 | 28 | $21.64 | $606 |
| 96160 E&M - Miscellaneous | Office | 13 | 13 | $1.75 | $22.8 |
By year: 2022 $304K for 40,024 services; 2023 $271K for 37,144 services; 2024 $220K for 32,522 services.
Medicare prescription drug claims, 2024
In 2024, the drug Brian D Jackson prescribed most often to Medicare patients was Montelukast Sodium, with 496 prescriptions and refills. In total Brian D Jackson wrote 3,385 Medicare prescriptions that cost $640K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 496 | 935 | 116 | $3,524 |
| Ipratropium Bromide Generic | 390 | 580 | 137 | $12K |
| Azelastine Hcl Generic | 307 | 503 | 142 | $8,349 |
| Fluticasone Propionate Generic | 283 | 446 | 104 | $3,920 |
| Levocetirizine Dihydrochloride Generic | 264 | 476 | 73 | $2,387 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 259 | 338 | 111 | $8,213 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 237 | 319 | 48 | $205K |
| Breo Ellipta Fluticasone/Vilanterol | 181 | 227 | 31 | $89K |
| Famotidine Generic | 158 | 241 | 57 | $1,837 |
| Ventolin Hfa Albuterol Sulfate | 57 | 67 | 29 | $3,913 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 54 | 70 | 12 | $8,396 |
| Methylprednisolone Generic | 53 | 53 | 46 | $426 |
| Advair Hfa Fluticasone Propion/Salmeterol | 53 | 63 | 11 | $25K |
| Symbicort Budesonide/Formoterol Fumarate | 46 | 58 | 14 | $13K |
| Hydroxyzine Hcl Generic | 44 | 56 | 13 | $701 |
Brand drugs: 989 claims; generic drugs: 2,396 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Brian D Jackson $985 ($985 in general payments such as food, travel and fees) from 10 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $218.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 12 | $218 |
| GlaxoSmithKline, LLC. GSK | 13 | $198 |
| Novartis Pharmaceuticals Corporation NVS | 8 | $168 |
| ARS Pharmaceuticals Operations, Inc. SPRY | 5 | $106 |
| Abbvie Inc. ABBV | 1 | $100 |
| Abiomed JNJ | 2 | $63.59 |
| TELA Bio, Inc. TELA | 1 | $48.05 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $38.54 |
| Verona Pharma, Inc. VRNA | 1 | $23.28 |
| Paratek Pharmaceuticals, Inc. | 1 | $21.3 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.